SpiroChem is pleased to announce its participation in EFMC Medicinal Chemistry 2026, taking place in Basel, Switzerland from September 6–10, 2026.
The EFMC International Symposium on Medicinal Chemistry is a key meeting for the European medicinal chemistry and chemical biology community, bringing together scientists from industry and academia to exchange on advances across drug discovery and molecular sciences.
The five-day scientific program will cover a broad range of topics spanning medicinal chemistry, chemical biology and enabling technologies, including emerging approaches in molecular design, novel therapeutic modalities, structure-based drug discovery and new technologies supporting the discovery of innovative medicines.
Meet our team on-site:
Thomas Fessard – Chief Executive Officer and Co-Founder
Gerhard Müller – Chief Scientific Officer
Florent Beaufils – Chief Operating Officer
Laurence Jung – Innovative Solutions Developer
Join us at booth #19 in Basel to connect with our team and discuss how SpiroChem’s expertise in medicinal chemistry, synthetic chemistry and drug discovery can support your research programs, from the design and synthesis of innovative chemical matter through lead optimization and advanced discovery challenges.
We look forward to engaging with the medicinal chemistry and drug discovery community at EFMC 2026 and exploring new opportunities for scientific collaboration.
